A detailed history of Seven Mile Advisory transactions in Haleon PLC stock. As of the latest transaction made, Seven Mile Advisory holds 15,057 shares of HLN stock, worth $147,106. This represents 0.09% of its overall portfolio holdings.

Number of Shares
15,057
Previous 18,498 18.6%
Holding current value
$147,106
Previous $157 Million 20.81%
% of portfolio
0.09%
Previous 0.12%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$8.01 - $8.64 $27,562 - $29,730
-3,441 Reduced 18.6%
15,057 $124 Million
Q1 2024

May 08, 2024

SELL
$8.02 - $8.67 $2,975 - $3,216
-371 Reduced 1.97%
18,498 $157 Million
Q4 2023

Feb 09, 2024

BUY
$7.78 - $8.62 $35,842 - $39,712
4,607 Added 32.3%
18,869 $155 Million
Q3 2023

Nov 13, 2023

BUY
$7.85 - $8.94 $17,270 - $19,668
2,200 Added 18.24%
14,262 $119 Million
Q2 2023

Aug 08, 2023

BUY
$8.04 - $9.0 $96,978 - $108,558
12,062 New
12,062 $101 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $45.1B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Seven Mile Advisory Portfolio

Follow Seven Mile Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Mile Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Seven Mile Advisory with notifications on news.